<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ha K</submitter><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Natural Science Foundation of China</funding><pagination>2225-2232</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8767556</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(6)</volume><pubmed_abstract>Platelets play a prominent role in multiple diseases, in particular arterial and venous thrombosis and also in atherosclerosis and cancer. To advance the &lt;i>in vivo&lt;/i> study of the biological activity of this cell type from a basic experimental focus to a clinical focus, new translatable platelet-specific molecular imaging agents are required. Herein, we report the development of a near-infrared fluorescence probe based upon tirofiban, a clinically approved small-molecule glycoprotein IIb/IIIa inhibitor (GPIIb/IIIa). Through &lt;i>in vitro&lt;/i> experiments with human platelets and &lt;i>in vivo&lt;/i> ones in a murine model of deep-vein thrombosis, we demonstrate the avidity of the generated probe for activated platelets, with the added benefit of a short blood half-life, thereby enabling rapid &lt;i></pubmed_abstract><journal>ACS sensors</journal><pubmed_title>&lt;i>In Vivo&lt;/i> Platelet Detection Using a Glycoprotein IIb/IIIa-Targeted Near-Infrared Fluorescence Imaging Probe.</pubmed_title><pmcid>PMC8767556</pmcid><funding_grant_id>R01HL133153</funding_grant_id><funding_grant_id>R01 HL144550</funding_grant_id><funding_grant_id>R01HL144550</funding_grant_id><funding_grant_id>R01 HL133153</funding_grant_id><funding_grant_id>R01HL150538</funding_grant_id><funding_grant_id>R01 HL122388</funding_grant_id><funding_grant_id>R01 HL150538</funding_grant_id><funding_grant_id>R01 HL137913</funding_grant_id><funding_grant_id>R01HL137913</funding_grant_id><funding_grant_id>R01HL122238</funding_grant_id><funding_grant_id>81800431</funding_grant_id><funding_grant_id>R01 HL122238</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Kawamura Y</pubmed_authors><pubmed_authors>Jaffer FA</pubmed_authors><pubmed_authors>Mauskapf A</pubmed_authors><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>McCarthy JR</pubmed_authors><pubmed_authors>Ha K</pubmed_authors><pubmed_authors>Orii M</pubmed_authors><pubmed_authors>Hilderbrand SA</pubmed_authors><pubmed_authors>Kessinger CW</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>In Vivo&lt;/i> Platelet Detection Using a Glycoprotein IIb/IIIa-Targeted Near-Infrared Fluorescence Imaging Probe.</name><description>Platelets play a prominent role in multiple diseases, in particular arterial and venous thrombosis and also in atherosclerosis and cancer. To advance the &lt;i>in vivo&lt;/i> study of the biological activity of this cell type from a basic experimental focus to a clinical focus, new translatable platelet-specific molecular imaging agents are required. Herein, we report the development of a near-infrared fluorescence probe based upon tirofiban, a clinically approved small-molecule glycoprotein IIb/IIIa inhibitor (GPIIb/IIIa). Through &lt;i>in vitro&lt;/i> experiments with human platelets and &lt;i>in vivo&lt;/i> ones in a murine model of deep-vein thrombosis, we demonstrate the avidity of the generated probe for activated platelets, with the added benefit of a short blood half-life, thereby enabling rapid &lt;i></description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-25T22:22:16.996Z</modification><creation>2025-04-06T09:04:48.094Z</creation></dates><accession>S-EPMC8767556</accession><cross_references><pubmed>34056903</pubmed><doi>10.1021/acssensors.1c00124</doi></cross_references></HashMap>